Revance Therapeutics, Inc. Stock News

LOS ANGELES , Feb. 28, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) have opportunity to lead the securities fraud class action lawsuit.

BENSALEM, Pa. , Feb. 26, 2025 /PRNewswire/ -- The Law Offices of Howard G.

Investors can contact the law firm at no cost to learn more about recovering their losses

NEW YORK , Feb. 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

LOS ANGELES , Feb. 20, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC). IF YOU SUFFERED A LOSS ON YOUR REVANCE INVESTMENTS, CLICK HERE BEFORE MARCH 4, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIE...

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Revance Therapeutics, Inc. (NASDAQ: RVNC) securities between February 29, 2024 and December 6, 2024. Revance is a biotechnology company that develops, manufactures, and commercializes neuromodulators for various aesth...

LOS ANGELES , Feb. 14, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) have opportunity to lead the securities fraud class action lawsuit.

NEW YORK , Feb. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.